Palvella Therapeutics (PVLA) Stock Chart & Stock Price History $63.64 +1.01 (+1.61%) As of 10:20 AM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Palvella Therapeutics Stock Price Performance The Palvella Therapeutics (PVLA) stock chart highlights key performance trends across multiple timeframes. Since the beginning of the year, the stock increased 430.33%. In the past month, the stock has increased 18.93%, reflecting recent market activity. As of the latest close, Palvella Therapeutics traded at $62.63 with a market cap of $692.69 million and volume of 240,785 shares. Receive PVLA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Palvella Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+6.80%1 Month Performance+18.93%3 Month Performance+163.85%Year-To-Date Performance+430.33% PVLA Stock Chart for Friday, October, 3, 2025 PVLA Chart by TradingView Palvella Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/02/2025$63.23$62.63-0.95%$64.75$60.49240,785 shs$692.69 million10/01/2025$62.69$63.23+0.86%$64.50$61.71129,691 shs$699.32 million09/30/2025$62.25$62.69+0.71%$65.57$62.02237,654 shs$693.35 million09/29/2025$59.59$62.25+4.46%$63.39$59.16278,555 shs$688.49 million09/26/2025$57.69$59.59+3.29%$61.00$58.16200,729 shs$659.07 million09/25/2025$58.87$57.69-2.00%$60.03$57.33119,549 shs$638.05 million09/24/2025$56.69$58.87+3.85%$61.30$56.55246,615 shs$651.10 million09/23/2025$58.71$56.69-3.44%$59.60$56.56262,507 shs$626.99 million09/22/2025$58.24$58.71+0.81%$60.31$57.92173,504 shs$649.33 million09/19/2025$59.04$58.24-1.36%$63.12$56.22326,756 shs$644.13 million Get the Latest News and Ratings for PVLA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Palvella Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 09/18/2025$56.57$59.04+4.37%$61.40$56.29234,667 shs$652.98 million09/17/2025$54.51$56.57+3.78%$57.84$54.48238,924 shs$625.66 million09/16/2025$54.63$54.51-0.22%$55.08$54.2890,800 shs$602.88 million09/15/2025$56.84$54.63-3.89%$57.30$53.30105,500 shs$604.21 million09/12/2025$58.45$56.84-2.75%$59.32$54.83147,562 shs$628.65 million09/11/2025$59.73$58.45-2.14%$61.48$57.70137,395 shs$646.46 million09/10/2025$56.71$59.73+5.33%$60.97$55.8389,476 shs$660.61 million09/09/2025$55.02$56.71+3.07%$56.78$54.4073,867 shs$627.21 million09/08/2025$55.68$55.02-1.19%$56.60$52.8271,179 shs$608.52 million09/05/2025$54.14$55.68+2.84%$58.22$52.36173,449 shs$615.82 million09/04/2025$53.51$54.14+1.18%$54.15$51.54128,454 shs$598.79 million09/03/2025$52.71$53.51+1.52%$56.77$51.3850,519 shs$591.82 million09/02/2025$54.15$52.71-2.66%$54.67$50.8288,605 shs$582.97 million Related Companies MLYS Stock Chart BHC Stock Chart IBRX Stock Chart CPRX Stock Chart BEAM Stock Chart TARS Stock Chart IDYA Stock Chart BLTE Stock Chart AGIO Stock Chart ETNB Stock Chart Receive PVLA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Palvella Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PVLA) was last updated on 10/3/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredU.S. Government Sparking Crypto RallyU.S. Puts GDP on the Blockchain Could this spark the next crypto supercycle? Discover the altcoins poised t...Crypto 101 Media | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredShots officially fired…Elon Musk just declared war on the wireless giants with a $17 billion spectrum deal that gives SpaceX the righ...Brownstone Research | SponsoredIs Nvidia about to Trigger Another 150X Opportunity?Nvidia gave investors a chance to make more than 150 times their money with its AI chips, known as graphics pr...InvestorPlace | SponsoredChina’s message to TrumpPorter Stansberry says this bull market is past the “safe zone” and racing toward an event horizon — and in hi...Porter & Company | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Palvella Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Palvella Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
